143 related articles for article (PubMed ID: 11999646)
21. NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs.
Hashimoto N; Yamashita T; Fujikura N; Tsuruzoe N
Europace; 2007 Apr; 9(4):246-51. PubMed ID: 17350982
[TBL] [Abstract][Full Text] [Related]
22. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Pagé PL; Hassanalizadeh H; Cardinal R
Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
[TBL] [Abstract][Full Text] [Related]
23. [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter].
Maykov EB; Yuricheva YA; Mironov NY; Sokolov SF; Golitsyn SP; Rozenshtraukh LV; Chazov EI
Ter Arkh; 2015; 87(1):38-48. PubMed ID: 25823268
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model.
Kumagai K; Nakashima H; Gondo N; Saku K
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):880-4. PubMed ID: 12890053
[TBL] [Abstract][Full Text] [Related]
25. Atrial fibrillation and atrial flutter: medical management.
Chen J
Clin Geriatr Med; 2012 Nov; 28(4):635-47. PubMed ID: 23101574
[TBL] [Abstract][Full Text] [Related]
26. Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs.
Platou ES; Refsum H
J Cardiovasc Pharmacol; 1982; 4(5):839-46. PubMed ID: 6182417
[TBL] [Abstract][Full Text] [Related]
27. Effects of Intrinsic and Extrinsic Cardiac Nerves on Atrial Arrhythmia in Experimental Pulmonary Artery Hypertension.
Zhao Q; Deng H; Jiang X; Dai Z; Wang X; Wang X; Guo Z; Hu W; Yu S; Yang B; Tang Y; Huang C
Hypertension; 2015 Nov; 66(5):1042-9. PubMed ID: 26418021
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.
Guichard JB; Naud P; Xiong F; Qi X; L'Heureux N; Hiram R; Tardif JC; Cartier R; Da Costa A; Nattel S
J Am Coll Cardiol; 2020 Jul; 76(4):374-388. PubMed ID: 32703507
[TBL] [Abstract][Full Text] [Related]
29. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
[TBL] [Abstract][Full Text] [Related]
30. Assessment of local atrial repolarization in a porcine acetylcholine model of atrial flutter and fibrillation.
Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Molyvdas PA
Acta Cardiol; 2009 Feb; 64(1):59-64. PubMed ID: 19317299
[TBL] [Abstract][Full Text] [Related]
31. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
[TBL] [Abstract][Full Text] [Related]
32. Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart.
Hayashi H; Fujiki A; Tani M; Usui M; Inoue H
J Cardiovasc Pharmacol; 1998 Jan; 31(1):101-7. PubMed ID: 9456284
[TBL] [Abstract][Full Text] [Related]
33. Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.
Ohmura K; Kobayashi Y; Miyauchi Y; Endoh Y; Atarashi H; Katoh T; Takano T
Pacing Clin Electrophysiol; 2003 Mar; 26(3):692-702. PubMed ID: 12698669
[TBL] [Abstract][Full Text] [Related]
34. [Sinus node functions, sinoatrial conduction, atrial conductivity after incipient paroxysms of atrial fibrillation and flutter in patients with ischemic heart disease].
Olesin AI; Shabrov AV; Razumova TV; Sinenko VI; Aleksandrov VS
Ter Arkh; 2001; 73(12):40-4. PubMed ID: 11858106
[TBL] [Abstract][Full Text] [Related]
35. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
Aidonidis I; Doulas K; Hatziefthimiou A; Tagarakis G; Simopoulos V; Rizos I; Tsilimingas N; Molyvdas PA
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):94-101. PubMed ID: 22872232
[TBL] [Abstract][Full Text] [Related]
36. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
37. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
Khitri AR; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Kowey PR
J Cardiovasc Electrophysiol; 2012 May; 23(5):462-72. PubMed ID: 22171925
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillation.
Rahme MM; Cotter B; Leistad E; Wadhwa MK; Mohabir R; Ford AP; Eglen RM; Feld GK
Circulation; 1999 Nov; 100(19):2010-7. PubMed ID: 10556228
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a new class III drug niferidil in cardioversion of persistent atrial fibrillation and flutter.
Maykov EB; Yuricheva YA; Mironov NY; Sokolov SF; Golitsyn SP; Rosenshtraukh LV; Chazov EI
J Cardiovasc Pharmacol; 2014 Sep; 64(3):247-55. PubMed ID: 24785342
[TBL] [Abstract][Full Text] [Related]
40. Tedisamil in a chronic canine model of atrial flutter.
Fischbach PS; Johnston PV; Friedrichs GS; Lucchesi BR
J Cardiovasc Pharmacol; 1999 Aug; 34(2):212-8. PubMed ID: 10445672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
